Chemed Corp: Form 10-Q for the period ended Mar 31, 2016
Filed with the SEC on May 2, 2016 and accepted by EDGAR at May 2, 2016, 11:15 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2016-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2016-01-01 to 2016-03-31 | $390.4m | us-gaap:SalesRevenueNet |
| Cost of revenue | 3 months2016-01-01 to 2016-03-31 | $278.4m | us-gaap:CostOfGoodsAndServicesSold |
| Selling, general and administrative | 3 months2016-01-01 to 2016-03-31 | $59.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2016-01-01 to 2016-03-31 | $44.4m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2016-01-01 to 2016-03-31 | $842.0k | us-gaap:InterestExpense |
| Income tax | 3 months2016-01-01 to 2016-03-31 | $15.8m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2016-01-01 to 2016-03-31 | $24.8m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2016-01-01 to 2016-03-31 | $1.45 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2016-01-01 to 2016-03-31 | $1.49 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2016-01-01 to 2016-03-31 | 17,170,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2016-01-01 to 2016-03-31 | $7.2m | us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations |
| Capital expenditure | 3 months2016-01-01 to 2016-03-31 | $11.5m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 3 months2016-01-01 to 2016-03-31 | $4.1m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 3 months2016-01-01 to 2016-03-31 | $52.5m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2016-03-31 | $15.2m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2016-03-31 | $179.9m | us-gaap:AssetsCurrent |
| Total assets | At period end2016-03-31 | $882.9m | us-gaap:Assets |
| Current liabilities | At period end2016-03-31 | $191.6m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2016-03-31 | $398.1m | us-gaap:Liabilities |
| Long-term debt | At period end2016-03-31 | $126.9m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2016-03-31 | $18.0m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2016-03-31 | $484.8m | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2016-03-31 | 16,557,177 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0001157523-16-005358. Last ingested by Listed: Oct 29, 2026, 09:14 ET. Listed shows no prices and gives no investment advice.